[HTML][HTML] Diagnosis and treatment of therapy-related acute myeloid leukemia
SA Strickland, N Vey - Critical reviews in oncology/hematology, 2022 - Elsevier
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior
cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, accounts for …
cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, accounts for …
Emerging therapies for acute myeloid leukemia
C Saygin, HE Carraway - Journal of hematology & oncology, 2017 - Springer
Acute myeloid leukemia (AML) is characterized by clinical and biological heterogeneity.
Despite the advances in our understanding of its pathobiology, the chemotherapy-directed …
Despite the advances in our understanding of its pathobiology, the chemotherapy-directed …
Acute myeloid leukemia
MR O'Donnell, CN Abboud, J Altman… - Journal of the National …, 2011 - jnccn.org
Overview I n 2010, approximately 12,330 people were diagnosed with and 8950 died of
acute myeloid leukemia (AML). 1 As the population ages, the incidence of AML, along with …
acute myeloid leukemia (AML). 1 As the population ages, the incidence of AML, along with …
Acute myeloid leukemia: 2014 Update on risk‐stratification and management
EH Estey - American journal of hematology, 2014 - Wiley Online Library
Overview: Evidence suggest that even patients aged 70 or above benefit from specific AML
therapy. The fundamental decision in AML then becomes whether to recommend standard …
therapy. The fundamental decision in AML then becomes whether to recommend standard …
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
RM Shallis, R Wang, A Davidoff, X Ma, AM Zeidan - Blood reviews, 2019 - Elsevier
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is
characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells …
characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells …
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Disease overview Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell
cancer characterized by unbridled proliferation of malignant marrow stem cells with …
cancer characterized by unbridled proliferation of malignant marrow stem cells with …
Acute myeloid leukemia: 2016 Update on risk‐stratification and management
E Estey - American journal of hematology, 2016 - Wiley Online Library
Evidence suggest that even patients aged 70 or above benefit from specific AML therapy.
The fundamental decision in AML then becomes whether to recommend standard or …
The fundamental decision in AML then becomes whether to recommend standard or …
Etiology and management of therapy-related myeloid leukemia
RA Larson - ASH Education Program Book, 2007 - ashpublications.org
The diagnosis of therapy-related myeloid leukemia (t-MDS/t-AML) identifies a group of high-
risk patients with multiple and varied poor prognostic features. These neoplasms are thought …
risk patients with multiple and varied poor prognostic features. These neoplasms are thought …
[HTML][HTML] Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia
Acute myeloid leukemia (AML) is primarily a disease of older adults. Many older patients
with AML are not candidates for intensive chemotherapy regimens aimed at inducing …
with AML are not candidates for intensive chemotherapy regimens aimed at inducing …
High-risk acute myelogenous leukemia: treatment today… and tomorrow
GJ Schiller - Hematology 2013, the American Society of …, 2013 - ashpublications.org
High-risk acute myelogenous leukemia (AML) constitutes a distinct subset of disease based
on clinical and biological characteristics and comprises a significant percentage of all cases …
on clinical and biological characteristics and comprises a significant percentage of all cases …